3rd Quarter - Report

RUSSELL MUELLER for PKD FOUNDATION

Firm
Client
Income
$10,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Obtained mention of PKD in Senate FY 2010 Defense Appropriations bill for research and clinical funding for PKD under Peer Reviewed Medical Research Program (Senate version of H.R. 3326), but did not obtain such funding in the House bill (H.R. 3326); Obtained sponsorship of National PKD Awareness Week Resolution for 2009 (S. Res. 241); Obtained PKD report language under FY 2010 HHS/NIH/NIDDK Appropriations House and Senate versions of H.R. 3293 for PKD forum and clinical treatment centers; Obtained funding under FY 2010 HHS Appropriations for PKD education efforts under House version of H.R. 3293. Medicare legislation: Obtain extension of immunosuppressive drug coverage under federal health programs (S. 565; H.R. 1458 and H.R. 3200).

LobbyistCovered position, as disclosed
RUSSELL J MUELLER —

Contacted: HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); SENATE

Bills named: S.Res. 241 (111th), H.R. 3326 (111th), S. 565 (111th), H.R. 1458 (111th), H.R. 3200 (111th), H.R. 3293 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.